Oppenheimer Upgrades NICE to Outperform with $150 Target
Sep 30, 2026, 10:37 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
A prestigious upgrade with a concrete target (NICE: $150) versus a ~$106 stock price signals meaningful upside and could attract fresh buyers, potentially compressing multiple expansion if momentum sustains.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer analyst Timothy Horan raised NICE from Perform to Outperform and assigned a $150 price target. With NICE trading around $106.81, the upgrade implies roughly 40% upside and could catalyze near-term buying interest, subject to management execution and broader market sentiment.
Oppenheimer upgrades NICE to Outperform; sets $150 target. Shares closed at $106.81.
Other banks lift outlooks on GO and PNFP.
Analyst upgrade may drive short-term upside for NICE.
No earnings data mentioned in the piece.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
NICE broke its Adhishthana Cakra, indicating potential long-term weakness. The stock is down about 41% from the breakdown point. Technical indicators suggest a move toward $67, th…